BR9912024A - Emplastros em gel contento esteróide e processo para a produção dos mesmos - Google Patents
Emplastros em gel contento esteróide e processo para a produção dos mesmosInfo
- Publication number
- BR9912024A BR9912024A BR9912024-0A BR9912024A BR9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A BR 9912024 A BR9912024 A BR 9912024A
- Authority
- BR
- Brazil
- Prior art keywords
- production
- steroid
- blended
- weight
- containing steroid
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 4
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 abstract 3
- 229960003338 crotamiton Drugs 0.000 abstract 3
- 239000004094 surface-active agent Substances 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Patente de Invenção: <B>"EMPLASTROS EM GEL CONTENDO ESTERóIDE E PROCESSO PARA A PRODUçãO DOS MESMOS"<D>. Emplastro em gel contendo esteróide contendo um esteróide como um ingrediente eficaz a 0,005 a 0,05% em peso, crotamitona como um estabilizador a 15% em peso ou menos e um tensoativo em uma base, onde a quantidade da crotamitona misturada é de 200 a 3000 vezes o peso do esteróide misturado e a quantidade do tensoativo misturado é de 1/20 a 1/5 vezes o peso da crotamitona misturada.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19593398A JP4456679B2 (ja) | 1998-07-10 | 1998-07-10 | ステロイド含有パップ剤及びその製造方法 |
| PCT/JP1999/003673 WO2000002563A1 (fr) | 1998-07-10 | 1999-07-07 | Cataplasmes contenant des steroides et procede de fabrication associe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9912024A true BR9912024A (pt) | 2001-05-29 |
Family
ID=16349396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9912024-0A BR9912024A (pt) | 1998-07-10 | 1999-07-07 | Emplastros em gel contento esteróide e processo para a produção dos mesmos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6432431B1 (pt) |
| EP (1) | EP1097712B1 (pt) |
| JP (1) | JP4456679B2 (pt) |
| KR (1) | KR20010072664A (pt) |
| CN (1) | CN1308537A (pt) |
| AT (1) | ATE250930T1 (pt) |
| BR (1) | BR9912024A (pt) |
| DE (1) | DE69911788T2 (pt) |
| ES (1) | ES2209456T3 (pt) |
| ID (1) | ID27765A (pt) |
| WO (1) | WO2000002563A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3655781B2 (ja) * | 1999-08-25 | 2005-06-02 | 帝國製薬株式会社 | ビタミンc又はその誘導体を配合したパップ剤 |
| JP5300038B2 (ja) * | 2000-03-07 | 2013-09-25 | 株式会社 資生堂 | 皮膚外用剤 |
| EP1287806A4 (en) * | 2000-05-15 | 2004-05-26 | Hisamitsu Pharmaceutical Co | WIPES PACKS |
| KR20030003769A (ko) * | 2000-05-31 | 2003-01-10 | 니찌방 가부시기가이샤 | 경피흡수형 스테로이드 외용제 |
| WO2001095889A1 (en) * | 2000-06-13 | 2001-12-20 | Hisamitsu Pharmaceutical Co., Inc. | Plaster |
| DE10260872B4 (de) * | 2002-12-23 | 2013-09-26 | Beiersdorf Ag | Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices |
| DE10260873A1 (de) | 2002-12-23 | 2004-07-15 | Beiersdorf Ag | Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin |
| US7993654B2 (en) * | 2002-12-23 | 2011-08-09 | Beiersdorf Ag | Self-adhesive polymer matrix containing sea algae extract |
| US7988990B2 (en) * | 2003-01-28 | 2011-08-02 | Teikoku Seiyaku Co., Ltd. | Thin aqueous cataplasm |
| US7998590B2 (en) | 2004-04-28 | 2011-08-16 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive material |
| WO2005105060A1 (ja) * | 2004-04-28 | 2005-11-10 | Hisamitsu Pharmaceutical Co., Inc. | 貼付剤 |
| JP4824336B2 (ja) * | 2004-05-07 | 2011-11-30 | ロート製薬株式会社 | 皮膚外用剤 |
| JP4824337B2 (ja) * | 2004-05-07 | 2011-11-30 | ロート製薬株式会社 | 皮膚外用剤 |
| US20070298089A1 (en) * | 2004-11-10 | 2007-12-27 | Masakazu Saeki | Drug for External Use and Adhesive Patch |
| CN103830179B (zh) * | 2014-03-24 | 2015-11-18 | 段懿玲 | 一种含有克罗米通的外用制剂及其制备工艺 |
| CN104984385B (zh) * | 2015-07-23 | 2017-08-29 | 山东维赫生物科技有限公司 | 一种水溶性医用预粘剂 |
| TWI833741B (zh) * | 2018-03-30 | 2024-03-01 | 日商樂敦製藥股份有限公司 | 外用油性固形組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5842168B2 (ja) * | 1974-12-20 | 1983-09-17 | トウコウヤクヒンコウギヨウ カブシキガイシヤ | 局所用剤の製造方法 |
| JPS5850964B2 (ja) * | 1978-03-07 | 1983-11-14 | 東興薬品工業株式会社 | ステロイド含有クリ−ム製剤およびその製造方法 |
| JPS58225009A (ja) * | 1982-06-23 | 1983-12-27 | Shionogi & Co Ltd | コルチコステロイド外用製剤 |
| JPH0236572B2 (ja) * | 1984-11-13 | 1990-08-17 | Hokuriku Pharmaceutical | Suteroidoo177monoesuteruganjukuriimuzai |
| JPS6351330A (ja) * | 1986-08-20 | 1988-03-04 | Teikoku Seiyaku Kk | ステロイド剤含有外用貼付剤 |
| JPS63201119A (ja) * | 1987-02-17 | 1988-08-19 | Kao Corp | 貼付剤組成物 |
| JPH0676327B2 (ja) * | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | ステロイド軟膏製剤 |
| JPH05271077A (ja) * | 1992-03-25 | 1993-10-19 | Lion Corp | パップ剤 |
| JP3029964B2 (ja) * | 1993-01-20 | 2000-04-10 | 久光製薬株式会社 | ステロイド類溶解剤及びステロイド類を主剤とする外用液剤 |
| JP2860748B2 (ja) * | 1993-12-24 | 1999-02-24 | エスエス製薬株式会社 | 安定な酪酸ヒドロコルチゾン含有クリーム剤 |
| JPH0853354A (ja) | 1994-08-11 | 1996-02-27 | Hisamitsu Pharmaceut Co Inc | 皮膚疾患用水性貼付剤 |
| AU692944B2 (en) * | 1994-11-18 | 1998-06-18 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneously absorbable patch |
-
1998
- 1998-07-10 JP JP19593398A patent/JP4456679B2/ja not_active Expired - Lifetime
-
1999
- 1999-07-07 ES ES99929738T patent/ES2209456T3/es not_active Expired - Lifetime
- 1999-07-07 WO PCT/JP1999/003673 patent/WO2000002563A1/ja not_active Ceased
- 1999-07-07 EP EP99929738A patent/EP1097712B1/en not_active Expired - Lifetime
- 1999-07-07 US US09/743,459 patent/US6432431B1/en not_active Expired - Lifetime
- 1999-07-07 CN CN99808417A patent/CN1308537A/zh active Pending
- 1999-07-07 DE DE69911788T patent/DE69911788T2/de not_active Expired - Lifetime
- 1999-07-07 BR BR9912024-0A patent/BR9912024A/pt not_active IP Right Cessation
- 1999-07-07 AT AT99929738T patent/ATE250930T1/de not_active IP Right Cessation
- 1999-07-07 KR KR1020017000017A patent/KR20010072664A/ko not_active Withdrawn
- 1999-07-07 ID IDW20010302A patent/ID27765A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010072664A (ko) | 2001-07-31 |
| EP1097712A1 (en) | 2001-05-09 |
| ES2209456T3 (es) | 2004-06-16 |
| US6432431B1 (en) | 2002-08-13 |
| ID27765A (id) | 2001-04-26 |
| JP2000026299A (ja) | 2000-01-25 |
| EP1097712A4 (en) | 2002-05-02 |
| EP1097712B1 (en) | 2003-10-01 |
| ATE250930T1 (de) | 2003-10-15 |
| DE69911788T2 (de) | 2004-05-06 |
| WO2000002563A1 (fr) | 2000-01-20 |
| CN1308537A (zh) | 2001-08-15 |
| JP4456679B2 (ja) | 2010-04-28 |
| DE69911788D1 (de) | 2003-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9912024A (pt) | Emplastros em gel contento esteróide e processo para a produção dos mesmos | |
| PT1311285E (pt) | Composicao farmaceutica liquida contendo um derivado de eritropoietina | |
| BR9406080A (pt) | Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
| PT801649E (pt) | Derivados de hidroxilamina uteis para aumentar a producao de proteinas moleculares adventicias e sua preparacao | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| BR9811099A (pt) | Inibidores de urocinase | |
| ES2150989T3 (es) | Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos. | |
| CO4910133A1 (es) | Antagonistas de 5-h[1f] | |
| MX9300603A (es) | Derivados tiaciclicos de piperidinilo. | |
| BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
| BRPI0411500A (pt) | pesticida para aplicar um aniquilamento de modo de ação fìsica, composição hidrocoloidal, método de aniquilamento de pestes em plantas pelo modo fìsico de operação e processo para a preparação de um pesticida | |
| KR960700061A (ko) | 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence) | |
| BR0011831A (pt) | Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos | |
| IT1264530B (it) | Impiego dei polisaccaridi nelle neuropatie atrofico degenerative | |
| ATE253820T1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
| BR9807145A (pt) | 2-metoxiimino-2-(piridiniloximetil) fenilacetamidas com derivados de ácido carboxìlico no anel de piridina como fungicidas. | |
| AR013163A1 (es) | Uso de composiciones que contienen diclorofenil imidazoldioxolano para la preparacion de un medicamento para tratar la dermatitis seborreica, caspa,psoriasis y acne, composiciones propiamente dichas, y un articulo de fabricacion que contiene dicha composicion | |
| BR9814284A (pt) | Composições e métodos para regulação de fagocitose e expressão de icam-1 | |
| MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
| BR9808956A (pt) | Composição pesticida | |
| ATE83668T1 (de) | Pflaster zur transdermalen anwendung. | |
| AR016044A1 (es) | Composiciones farmaceuticas que comprenden cantidades antialergenicas efectivas de descarboniletoxiloratadina | |
| ES2133918T3 (es) | Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |